This website uses cookies
Read our Privacy policy and Terms of use for more information.
Christina Farr is the editor-in-chief/CEO of Second Opinion, and a GP at early-stage healthcare fund Scrub Capital.
Rising compute costs have biotech firms rethinking how they use large language models.
We’re about to enter into an era of minimal funding, then exit
From fertility and menopause to sleep and recovery, Oura is building one of the largest consumer health datasets focused on women.
Plus: updates on the Ebola outbreak, CMS' prior authorization program, and Healthcare.gov
Here’s what employers are likely to do about it...
Plus all the most important news of the week!
Our next premium webinar is a Q&A with veteran payer CEO Don Antonucci
It's called SOS.
This is the model proven by Grow Therapy, now valued at $3B
Second Opinion partnered with Confido to determine which companies should make the cut.
There's a lot more of them than we expected!
We are entering into the era of Navigation 2.0.
AI, your news of the week, and an invitation ?
“We have a truth-telling problem in US healthcare.”
The biggest deals and news of the week, plus an interview with Embold Health president and founder Daniel Stein
A healthcare VC/former journalist and equities research analyst team up for the hot take!
Klomp, a healthcare entrepreneur, was recently tapped to lead the department of Health and Human Services under Kennedy.
Plus the latest on MA enrollment, the ACCESS model, and the durability of the weight management business
Researchers are raising important questions related to patient safety
How AI is streamlining patient access, reducing front-desk burnout, and driving measurable revenue in specialty care practices, without adding staff.
The program is designed to reward companies for tech-enabled care
Costs are rising, markets are moving, and the system is under pressure to adapt.